#ExpertAnswers: Gwendalyn Randolph on Immunity
Airdate: Thursday, November 25, 2021 Season: 8 Episode: 64
Guest: Gwendalyn J Randolph
Dr. Gwendalyn Randolph from the Washington University School of Medicine, St Louis answers questions from a recent webinar discussing strategies that the intestine uses to limit the dissemination of inflammatory signals in the venous and lymphatic vasculature.
For more information or to watch the webinar, click here.
Associated Webinar: Immunophysiological Mechanisms that Limit Dissemination of Microbial Signals from the Intestine
Similar Podcasts
Industry Insights with Crown Bioscience: Targeting T Cells Within the Cancer Immunity Cycle
Saskia De Man, Marrit Putker, and Pirouz Daftarian from Crown Bioscience discuss the impact of T cell-directed immunotherapy on the cancer-immunity cycle.
#ExpertAnswers: Rajendra Kumari and Gera Goverse on the Cancer Immunity Cycle
Rajendra Kumari and Gera Goverse provide an overview of the cancer immunity cycle and present several methods, techniques, and model systems for immuno-oncology research.
#ExpertAnswers: Amy Sheng on Antibody Screening and Discovery
Amy Sheng provides an overview of antibody screening platforms and presents applications and case studies using the Beacon® platform for antibody discovery.
Related Content
Analyzing the Suppressive TME in in Vitro Based Assays
Experts describe suppressive tumor immune microenvironment compartments and patient-derived tissue technologies capable of recapitulating the TME for clinically-relevant studies.
Real-time IntraVital Microscopy (IVM): In Vivo Cellular-level Imaging of Internal Organs in a Live Animal
Join Pilhan Kim, PhD for an in-depth discussion on the All-in-One intravital two-photon and confocal microscopy system.
Not All IBD Models Are Created Equally – How Differences Between Experimental IBD Models Can Impact Your Drug Development Program
Experts discuss differences between animal models of IBD and highlight the advantages of using immune cell-induced and spontaneous mouse models of colitis for drug development.